Predictive Biosciences announced this week that Jay Moorin has joined its board of directors.
Moorin is a founding partner at ProQuest Investments, which led a recent Series C funding round through which Predictive raised $25 million (see related story, this issue).
Prior to founding ProQuest, Moorin was CEO of Magainin Pharmaceuticals (now Genaera), and prior to that he was managing director of healthcare banking at Bear Stearns.